NCT00710554 A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia Status COMPLETED Phase PHASE3
NCT00710424 A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy Status COMPLETED Phase PHASE3
NCT00702468 Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00693602 Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma Status COMPLETED Phase PHASE1
NCT00681538 A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS) Status COMPLETED Phase PHASE3
NCT00678795 A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00675948 Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain Status COMPLETED Phase PHASE3
NCT00674609 A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy Status COMPLETED Phase PHASE3
NCT00670696 A Study to Compare the Efficacy of Rapydan Versus Tetracaine Gel Status WITHDRAWN Phase PHASE4
NCT00641186 Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD) Status COMPLETED Phase PHASE2
NCT00628498 Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study Status COMPLETED Phase PHASE3
NCT00598078 Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor Status COMPLETED Phase PHASE2
NCT00594945 Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures Status COMPLETED Phase PHASE2
NCT00514995 Sodium Oxybate in the Treatment of Binge Eating Disorder Status COMPLETED Phase PHASE2/PHASE3
NCT00457951 A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD Status TERMINATED Phase PHASE2
NCT00423813 A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia. Status COMPLETED Phase PHASE3